Bajaj Healthcare Limited
Bajaj HealthCare Limited, a pharmaceutical company, develops, manufactures, markets, and sells active pharmaceutical ingredient, intermediates, and finished dosage forms and nutraceuticals for pharmaceutical, nutraceuticals, and food industries in India and internationally. The company offers active pharmaceutical ingredient in various therapeutic categories, including anti-diabetic, antibiotic, … Read more
Bajaj Healthcare Limited (BAJAJHCARE) - Total Liabilities
Latest total liabilities as of September 2025: ₹3.52 Billion INR
Based on the latest financial reports, Bajaj Healthcare Limited (BAJAJHCARE) has total liabilities worth ₹3.52 Billion INR as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Bajaj Healthcare Limited - Total Liabilities Trend (2011–2025)
This chart illustrates how Bajaj Healthcare Limited's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Bajaj Healthcare Limited Competitors by Total Liabilities
The table below lists competitors of Bajaj Healthcare Limited ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
DLP Resources Inc
OTCQB:DLPRF
|
USA | $521.24K |
|
PAMT CORP
NASDAQ:PAMT
|
USA | $487.43 Million |
|
International Meal Company Alimentação S.A
SA:MEAL3
|
Brazil | R$1.38 Billion |
|
Etteplan Oyj
HE:ETTE
|
Finland | €181.83 Million |
|
GOCL Corporation Limited
NSE:GOCLCORP
|
India | ₹7.54 Billion |
|
ICC Holdings Inc
NASDAQ:ICCH
|
USA | $163.61 Million |
|
Vistin Pharma ASA
OL:VISTN
|
Norway | Nkr127.45 Million |
|
Ardea Resources Ltd
AU:ARL
|
Australia | AU$28.99 Million |
Liability Composition Analysis (2011–2025)
This chart breaks down Bajaj Healthcare Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.75 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.72 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.42 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Bajaj Healthcare Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Bajaj Healthcare Limited (2011–2025)
The table below shows the annual total liabilities of Bajaj Healthcare Limited from 2011 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-03-31 | ₹3.67 Billion | -24.63% |
| 2024-03-31 | ₹4.87 Billion | -8.81% |
| 2023-03-31 | ₹5.34 Billion | +35.95% |
| 2022-03-31 | ₹3.93 Billion | +46.93% |
| 2021-03-31 | ₹2.67 Billion | +53.45% |
| 2020-03-31 | ₹1.74 Billion | +26.42% |
| 2019-03-31 | ₹1.38 Billion | -10.86% |
| 2018-03-31 | ₹1.55 Billion | +28.51% |
| 2017-03-31 | ₹1.20 Billion | -0.12% |
| 2016-03-31 | ₹1.20 Billion | +12.75% |
| 2015-03-31 | ₹1.07 Billion | -6.22% |
| 2014-03-31 | ₹1.14 Billion | +12.27% |
| 2013-03-31 | ₹1.01 Billion | +11.64% |
| 2012-03-31 | ₹908.41 Million | +23.55% |
| 2011-03-31 | ₹735.24 Million | -- |